SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Klaria Pharma Plans Potential US Launch of Migraine Treatment With Partner

Klaria Pharma plans a potential U.S. launch of a migraine treatment with a partner.

Related stories